CANDACE SCHNEE: Open Payments
NPI 1093460487 · BLUE ASH, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$463 in 4 payments from 4 companies in 2025. Trend: 2023 $371 · 2024 $712 · 2025 $463
Food & beverage: $463
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $136 |
| Aimmune Therapeutics, Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $117 |
| ACADIA Pharmaceuticals Inc | 1 | $85 |
Products named: INGREZZA, ZENPEP, REXULTI, NUPLAZID.
Industry payments across OH — which companies pay providers there.
